KR20090010756A - Gum comprising haematococcus, astaxanthin - Google Patents
Gum comprising haematococcus, astaxanthin Download PDFInfo
- Publication number
- KR20090010756A KR20090010756A KR1020070074117A KR20070074117A KR20090010756A KR 20090010756 A KR20090010756 A KR 20090010756A KR 1020070074117 A KR1020070074117 A KR 1020070074117A KR 20070074117 A KR20070074117 A KR 20070074117A KR 20090010756 A KR20090010756 A KR 20090010756A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- astaxanthin
- gum
- parts
- powder
- Prior art date
Links
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 24
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 24
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 24
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 24
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 24
- 241000168525 Haematococcus Species 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 9
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000010447 xylitol Nutrition 0.000 claims abstract description 6
- 239000000811 xylitol Substances 0.000 claims abstract description 6
- 229960002675 xylitol Drugs 0.000 claims abstract description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 6
- 239000000845 maltitol Substances 0.000 claims abstract description 4
- 235000010449 maltitol Nutrition 0.000 claims abstract description 4
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims abstract description 4
- 229940035436 maltitol Drugs 0.000 claims abstract description 4
- 235000003599 food sweetener Nutrition 0.000 claims abstract 2
- 239000003765 sweetening agent Substances 0.000 claims abstract 2
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 3
- 229940112822 chewing gum Drugs 0.000 abstract description 6
- 235000015218 chewing gum Nutrition 0.000 abstract description 6
- 239000002304 perfume Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 6
- 208000003464 asthenopia Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 235000015110 jellies Nutrition 0.000 description 5
- 239000008274 jelly Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000239659 Eucalyptus pulverulenta Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004133 fatty acid degradation Effects 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000008629 immune suppression Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 229940097156 peroxyl Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000007539 photo-oxidation reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
- A23G2200/14—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing fruits, nuts, e.g. almonds, seeds, plants, plant extracts, essential oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/202—Algae extracts
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
본 발명은 헤마토코쿠스(Haematococcus pluvialis)추출물 또는 아스타잔틴(Astaxanthin)를 포함하는 껌에 대한 발명이다. The present invention relates to a gum comprising Haematococcus pluvialis extract or Astaxanthin.
일반적으로 아스타잔틴은 생활주변에서 쉽게 접할 수 없는 물질이다.아스타잔틴은 식품의약안정청으로부터 눈의 피로 개선에 도움을주는 기능성원료로 인정받은받은바 있으나 원료에서 나타나는 특이한 풍미로 일반인들은 향과 맛에서 거부감을 느끼는등 복용 및 섭취가 용이하지 않은 단점이 있었다. In general, astaxanthin is a substance that is not easily encountered in everyday life. Astaxanthin has been recognized by the Food and Drug Administration as a functional ingredient to help improve eye fatigue, but it is an unusual flavor that appears in raw materials. There was a drawback that it was not easy to take and consume, such as feeling rejection in taste.
따라서 본 발명이 이루고자 하는 기술적 과제는상기의 문제점을 해결하고 상기의 필요성에 의하여 안출된 것으로 본 발명의 목적은 껌을 씹음과 동시에 눈의 피로개선에 도움을 주는 아스타잔틴을 함유하는 껌의 제조방법을 제공하는것이다. Therefore, the technical problem to be achieved by the present invention is to solve the above problems and to be devised by the necessity of the above object of the present invention is to produce a gum containing astaxanthin chewing gum and at the same time helps to improve eye fatigue To provide a way.
본 발명은 헤마토코쿠스(Haematococcus pluvialis)추출물 또는 아스타잔틴(Astaxanthin)를 보다 쉽게 섭취 할수 있도록 하는것이다. The present invention is to facilitate the intake of hematococcus (Haematococcus pluvialis) extract or astaxanthin (Astaxanthin).
껌 베이스와 배합후 분말 타정Powder tableting with gum base
본 발명에 따른 헤마토코쿠스(Haematococcus pluvialis)추출물 또는 아스타잔틴성분을 포함하는 타정껌 조성물은 눈의 피로 개선 및 예방에 효과적이다. Haematococcus pluvialis extract according to the present invention or a tableting gum composition containing astaxanthin component is effective for improving and preventing eye fatigue.
상기 기술적 과제를 달성하기 위하여, 본 발명은 지용성물질인 아스타잔틴(Astaxanthin)을 껌과 함께 배합하는 것을 특징으로 한다.In order to achieve the above technical problem, the present invention is characterized in that the fat-soluble astaxanthin (Astaxanthin) is combined with the gum.
보다 구체적으로, 전체중량의 15~75중량%의 껌베이스와 전체중량의 1~15중량%의 아스타잔틴을 포함하는 껌조성물을 제공한다. More specifically, it provides a gum composition comprising 15 to 75% by weight of the total weight of the gum base and 1 to 15% by weight of astaxanthin.
본 발명에 있어 상기조성물은 말니톨분말0~30%중량부,말티톨분말0~30%중량부 자일리톨분말0~30%중량부 향료0,5~5.0%중량부를 포함하는 것이 바람직하며 상기조성물을 타정방식으로 제조함이 중요하다. 여기에 가장 중요한 것은 지용성 물질인 헤마토코쿠스(Haematococcus pluvialis)추출물 또는 아스타잔틴(Astaxanthin)을 껌과 함께 융화시켜 배합하는 기술이라 할수 있다. In the present invention, the composition is preferably 0 to 30% by weight of maltitol powder, 0 to 30% by weight of maltitol powder 0 to 30% by weight of xylitol powder 0,5 to 5.0% by weight of fragrance and the composition It is important to manufacture by compression Most importantly, the fat-soluble substance Haematococcus pluvialis extract or astaxanthin can be blended with a gum to combine it.
이하 본 발명의 아스타잔틴(Astaxanthin)껌 조성물에 대하여 보다 상세히 설명한 다.Hereinafter, the astaxanthin gum composition of the present invention will be described in more detail.
본 발명에서는 국내식약청에서 기능성 원료로서 개별인증된 헤마토코쿠스원료에 대한 지표성분(또는 기능성분) 아스타잔(Astaxanthin)틴이 실험을 통해 눈의 피로도 개선에 효과가 있음을 확인하고, 이를 토대로 본 발명을 완성하게 되었다.In the present invention, it was confirmed that the indicator component (or functional ingredient) Astaxanthin for the hematococcus raw material individually certified as a functional raw material by the Korea Food and Drug Administration was effective in improving eye fatigue through experiments. The present invention has been completed.
본 발명에 사용되는 "헤마토코쿠스(Haematococcus pluvialis)" 건강기능식품공전 내에 눈의 피로도개선으로 기능인정된 원료이다. 여기서 지표성분인 아스타잔틴(Astaxanthin)의 효과가 눈의피로 개선에 도움이 되는 성분이다. 아스타잔틴(Astaxanthin)의 중요 4대 작용은 우선 노화방지제(antioxidant)역활로 DNA, 단백질, 지질막을 손상시켜 노화의 원인이 되는 자유라디칼 (Hydroxyl, Peroxyl radicals)과 활성 산소종(Singlet Oxygen)은 신진대사 과정에서 발생 손상으로부터 다른 분자와 조직을 보호하고 Singlet oxygen의 활성 에너지를 흡수 (강력한 항산화제) 지방산 분해에 의해 생성되는 자유라디칼의 사슬 반응 을 억제 과산화로부터 인지질과 다른 지질 막을 보호하는 역할을 한다. 둘째 역할은 자외선보호역활(UV-Protectant) 햇빛, 특히 UV에의 노출은 Singlet oxygen과 자유라디칼을 생성시키고 지질과 피부 조직의 산화적 손상을 초래하는것으로부터 카로티노이드는 UV로부터 피부 조직을 보호하는데 중요한 역할을 하고, β-carotene이나 Lutein보다 UV로 인한 지질의 산화 방지에 효과적 이다. 셋째는 피부 건강(Skin Health)에 도움 되는 것으로 피부의 햇빛 과다 노출은 sunburn을 초래하고 산화, 염증, 면역 억제, 노화, 심지어는 피부암을 유발할 수 있는데 아스타잔틴은 β-carotene이나 Lutein보다 UV-induced photooxidation에 대한 보호 효과가 뛰어나고 강력한 sun-protect역 활을 한다. 넷째는 염증예방(anti inflammation) 활성산소종(ROS)은 염증 자리에서 Phagocytic leucocytes(식세포의 백혈구)에 의해 방출 되어 염증 자리에서 활성화된 호중성 백혈구는 항산화제인 비타민의 감소, 산화적 스트레스와 지질과산화의 증가를 초래 시키는 것을 아스타잔틴(Astaxanthin)은 염증을 감소시키고 염증 반응에서의 변화와 연관되게 하는 역할을 한다. 우선 "헤마토코쿠스(Haematococcus pluvialis )를 껌과 배합하기 위해 지용성물질성분으로 껌과 씹어 졌을때 지표성분이 껌 베이스와 융화되어 더 이상의 유효 성분이 용출 되지 않는 것을 젤라틴과 헤마토코쿠스를 섞어 젤리와 시킨후 이를 분말화 해 분말 껌베이스와 섞어 타정한다. 여기서 중요한 것은 헤마토코쿠스젤리가 입에서 치력(齒力)에 으깨지지 않도록 하기 위해 딱딱할정도의 강도를 유지해 분쇄한다. 분쇄한 분말은 씹음과 동시에 껌베이스분말과 분리 될 수 있도록 오일코팅막을 입혀준다. 이는 껌베이스 타정분말과 함께 혼합하여 압력에 의해 타정된 조성물은 씹었을때 으깨 지면서 헤마토코쿠스젤리와 껌베이스 속의 당성분은 침과함께 섭취하게 되고 시간이 경과한 후에는 껌베이스만 남게하는 것이다."Haematococcus pluvialis" used in the present invention is a raw material functionally recognized by improving the fatigue of the eye in the health functional food code. Here, astaxanthin, an index component, is effective in improving eye fatigue. Astaxanthin's four major actions are antioxidants: free radicals (Hydroxyl, Peroxyl radicals) and active oxygen species (Singlet Oxygen) that damage DNA, proteins, and lipid membranes, causing aging. Protects other molecules and tissues from damage caused by metabolism and absorbs the active energy of Singlet oxygen (a powerful antioxidant) Suppresses the chain reaction of free radicals produced by fatty acid degradation Protects phospholipids and other lipid membranes from peroxidation do. The second role is that UV-Protectant Sunlight, especially UV exposure, produces singlet oxygen and free radicals and causes oxidative damage to lipids and skin tissues, so carotenoids play an important role in protecting skin tissues from UV rays. It is more effective in preventing oxidation of lipids due to UV than β-carotene or lutein. Third, it helps skin health. Overexposure to the skin can lead to sunburn and can lead to oxidation, inflammation, immune suppression, aging, and even skin cancer. Astaxanthin is more UV-sensitive than β-carotene or Lutein. Excellent protection against induced photooxidation and strong sun-protection. Fourth, anti-inflammatory reactive oxygen species (ROS) are released from phagocytic leucocytes in the site of inflammation, and neutrophils activated in the site of inflammation reduce antioxidant vitamins, oxidative stress and lipid peroxidation. Astaxanthin acts to reduce inflammation and to associate it with changes in the inflammatory response. First, when gelatin was mixed with chewing gum as a fat-soluble substance to combine hematococcus (Haematococcus pluvialis) with chewing gum, it was mixed with gelatin and hematococcus to prevent the active ingredient from eluting. Jelly and then powdered and mixed with a powdered gum base to tablet, where the important thing is to crush and maintain a firm hardness to prevent hematococcus jelly from crushing in the mouth. The powder is coated with an oil coating film so that it can be separated from the gum base powder at the same time as it is chewed. Ingredients are eaten with saliva, leaving only the gum base after time.
상기의 조성물은 식품의약청 건강기능식품공전상의 아스타잔틴성분 섭취량을 일일 6mg으로 규정하고 있어 헤마토코쿠스 추출물속에는 5%의 아스타잔틴성분이 포함되어 있으므로 1일 기준섭취량을 3개로하고 껌 1개당(2gr)기준 40mg의 헤마토코쿠스성분을 포함하였다. 기타 성분은 껌의 역할도 할수 있도록 향료와 자일리톨 성분을 함유 하고 입냄새제거등의 기능을 할수 있도록 하였다.In the above composition, the intake of astaxanthin ingredient in the Food and Drug Administration's Health Functional Food Code is 6mg per day, and the hematococcus extract contains 5% astaxanthin ingredient, so the daily intake is three and 1 It contained 40 mg of hematococcus component per piece (2gr). Other ingredients contain fragrance and xylitol to play the role of gum, and also function to remove bad breath.
상기의 조성물은 각 구성물의 중량비 이하에서는 약효가 효과가 적고 , 그 이상에 서는 약효의 별차이가 없으므로 경제성을 고려하여 상기의 중량비를 선택 하였다.The composition of the composition is less than the weight ratio of each component, the drug efficacy is less, and there is no difference in the drug efficacy above, so the weight ratio was selected in consideration of economics.
이하 ,실시예를 통하여 본 발명을 더욱 상세하게 설명한다. Hereinafter, the present invention will be described in more detail with reference to Examples.
1.원료평량 1. Raw material basis weight
1)원료 조성비율대로 평량한다.1) Basis weight on raw material composition ratio.
2.제조 2. Manufacture
1)정백당30kg에 물 15L를 첨가한후 100℃까지 가열하여 융해한다.1) Add 15L of water to 30kg per white and melt it by heating up to 100 ℃.
2)그다음 분말한천 2kg에 물40L을 부가 하고 110℃에서 37동안 가열한다.2) Then add 40 L of water to 2 kg of powdered agar and heat at 110 ℃ for 37 minutes.
3)가열후 물엿94투입하고 여기에 헤마토코쿠스 5kg을 첨가하여 3분동안 교반한다.3) After heating, add 94 syrup and add 5 kg of hematococcus to it and stir for 3 minutes.
4)이후 사각용기에 넣어 취출시킨다음 상온에서 20시간이상 숙성시킨다.4) After taking it out in a square container, let it mature for at least 20 hours at room temperature.
5)숙성시킨후 분쇄기로 100mesh로 분쇄한다.5) After aging, grind to 100mesh with a grinder.
3.코팅3. Coating
1)분말 오브라이트로 코팅후 45~60℃에서 16시간동안 건조시켜 헤마토코쿠스 분말젤리를 얻는다.1) After coating with powder of light and dried for 16 hours at 45 ~ 60 ℃ to obtain hematococcus powder jelly.
실시예2: 타정껌 제조 방법Example 2 Preparation of Tablet Gum
1.원료평량 1. Raw material basis weight
1)원료 조성비율대로 평량한다.1) Basis weight on raw material composition ratio.
2.배합2.Combination
1)껌베이스, 자일리톨, 비타민C, L-멘톨을 원료 조성비율로 배합후 분말와 시킨다.1) Gum base, xylitol, vitamin C, and L-menthol are mixed with powder after mixing in the raw material composition ratio.
2)분말화된 분말과 헤마투코쿠스젤리 분말을 평량 비율로 믹서로 혼합한다.2) Mix the powdered powder and the hematococcus jelly powder in a mixer in a basis weight ratio.
3)혼환된 분말에 이산화규소와 스테아릭마그네슘을 넣어 100%의 배합을 만든다. 3) Add silicon dioxide and stearic magnesium to the blended powder to make 100% blend.
3.타정3. Tableting
1)타정기 혼합기에 배합 원료를 넣고 타정 한다. 1) Put the blended raw material into the tableting machine mixer and tablet.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070074117A KR20090010756A (en) | 2007-07-24 | 2007-07-24 | Gum comprising haematococcus, astaxanthin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070074117A KR20090010756A (en) | 2007-07-24 | 2007-07-24 | Gum comprising haematococcus, astaxanthin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20090010756A true KR20090010756A (en) | 2009-01-30 |
Family
ID=40489884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020070074117A KR20090010756A (en) | 2007-07-24 | 2007-07-24 | Gum comprising haematococcus, astaxanthin |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20090010756A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106689618A (en) * | 2016-11-21 | 2017-05-24 | 云南爱尔康生物技术有限公司 | Astaxanthin tabletting candy preparation method |
| ES2615161A1 (en) * | 2015-12-03 | 2017-06-05 | Malakium S.L. | Composition to make chewing gums (Machine-translation by Google Translate, not legally binding) |
| CN107259046A (en) * | 2017-06-07 | 2017-10-20 | 陕西必康制药集团控股有限公司 | Haematococcus pluvialis pressed candy with anti-oxidation function and preparation method thereof |
| CN108552398A (en) * | 2018-03-13 | 2018-09-21 | 云南爱尔康生物技术有限公司 | A kind of astaxanthin soft sweets and preparation method thereof |
-
2007
- 2007-07-24 KR KR1020070074117A patent/KR20090010756A/en not_active Application Discontinuation
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2615161A1 (en) * | 2015-12-03 | 2017-06-05 | Malakium S.L. | Composition to make chewing gums (Machine-translation by Google Translate, not legally binding) |
| CN106689618A (en) * | 2016-11-21 | 2017-05-24 | 云南爱尔康生物技术有限公司 | Astaxanthin tabletting candy preparation method |
| CN107259046A (en) * | 2017-06-07 | 2017-10-20 | 陕西必康制药集团控股有限公司 | Haematococcus pluvialis pressed candy with anti-oxidation function and preparation method thereof |
| CN108552398A (en) * | 2018-03-13 | 2018-09-21 | 云南爱尔康生物技术有限公司 | A kind of astaxanthin soft sweets and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7943182B2 (en) | Berry oils and products | |
| EP1830926B1 (en) | Oregano oral care compositions and methods of use thereof | |
| US9827208B2 (en) | Antioxidant dietary supplement compositions and methods for maintaining healthy skin | |
| KR101723588B1 (en) | Composition for mouth comprising camellia japonica l leaf extract and manufacturing method thereof | |
| KR20090010756A (en) | Gum comprising haematococcus, astaxanthin | |
| Gahlawat | Emerging new insights into significance and applications of Plant Pigments | |
| WO2019100923A1 (en) | Skin care composition and application thereof, and health care product | |
| Vyas et al. | Antioxidants in oral diseases and future prospects and their application in dentistry | |
| JP2007308396A (en) | Composition for asthenopia | |
| Narayan et al. | Punica granatum (Pomegranate) fruit and its relevance in oral hygiene | |
| Nagarajappa et al. | Role of free radicals and common antioxidants in oral health, an update. | |
| KR101916377B1 (en) | Composition for teeth whitening and preparation method therefor | |
| KR102283497B1 (en) | Stick jelly with the effect of antioxidation | |
| KR101010575B1 (en) | The composition for the atopic dermatitis improving with vinegar | |
| US20210085587A1 (en) | A tanning composition | |
| US20080279986A1 (en) | Food preparation in the form of a bar, containing functional ingredients capable of preventing degenerative phenomena caused by oxidizing agents | |
| KR102026659B1 (en) | Antibacterial toothpaste composition containing propolis extraction and manufacturing method thereof | |
| Molayem | Current evidence on the use of curcumin in modern periodontology-A narrative review | |
| Kamran et al. | Health perspectives of grape seed extract (GSE) | |
| RU2537902C2 (en) | Rock candy | |
| KR20140072792A (en) | Edible film composition comprising oregano oil and preparation method thereof | |
| GR1010258B (en) | Composition containing carrotenoids, vitamins, coenzyme q10, amino acids and metals for solar tanning without exposure to sun | |
| Manorama et al. | Identification of Chemical Constituents, Chromatographic profiling of PHE (Poly Herbal Extract) of selected Indian Medicinal Herbs and its Antioxidant activity Evaluation | |
| KR20120053374A (en) | Composition of toothpaste and method of preparing thereof | |
| Saleem et al. | Assessment of Antioxidant Potential of Selected plant stems traditionally used for Oral Care |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Withdrawal due to no request for examination |